Posted Jun. 29, 2012 at 7:18 a.m.

Premium Lock GSK may extend takeover bid, must face Avandia suit

Published: 2012-06-29 07:18:56
Updated: 2012-06-29 07:18:56

Print this blog post
DNA  DNA

Glaxo could extend its $2.6 billion hostile takeover bid for Human Genome Sciences next week. Meanwhile, a federal court rules that GSK must face a lawsuit from Humana about injuries related to Avandia....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll